Personalis, Inc. PSNL

Updated: 9 Aug 2026

NASDAQ | Biotech | Cancer genomics and precision oncology

No signal published yet

We already track Personalis and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Personalis free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Cancer genomics and precision oncology
We're already tracking Personalis, Inc. — here are the latest events we've registered

Recent News

  • On July 20, 2026, Tempus AI announced a definitive agreement to acquire Personalis in a deal valued at approximately $1.7 billion. Subsequently, on August 4, 2026, Personalis reported its second-quarter 2026 financial results, generating $22.4 million in revenue.

What Firelda Watch includes for Personalis, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Personalis, Inc. will be delivered in the same format.

Want to follow Personalis, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Personalis free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Personalis, Inc. PSNL
Personalis — follow and we'll monitor it
Follow Personalis free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.